TSXV - Delayed Quote CAD

Sirona Biochem Corp. (SBM.V)

0.0600 -0.0050 (-7.69%)
At close: April 24 at 2:59 PM EDT
Loading Chart for SBM.V
DELL
  • Previous Close 0.0650
  • Open 0.0650
  • Bid 0.0600 x --
  • Ask 0.0700 x --
  • Day's Range 0.0600 - 0.0650
  • 52 Week Range 0.0550 - 0.1800
  • Volume 10,000
  • Avg. Volume 45,014
  • Market Cap (intraday) 15.308M
  • Beta (5Y Monthly) -0.44
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0000
  • Earnings Date Jun 27, 2024 - Jul 1, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date Dec 27, 2006
  • 1y Target Est --

Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, develops and sells cosmetic and pharmaceutical active ingredients in Canada and France. Its programs include cosmetic skin lightener and diabetes drug; and other projects comprise the development of an anti-aging/cell protection library, novel anti-wrinkle compound, and anti-viral program. The company was formerly known as High Rider Capital Inc. and changed its name to Sirona Biochem Corp. in May 2009. Sirona Biochem Corp. was incorporated in 2006 and is headquartered in Vancouver, Canada.

www.sironabiochem.com

--

Full Time Employees

October 31

Fiscal Year Ends

Recent News: SBM.V

Performance Overview: SBM.V

Trailing total returns as of 4/24/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

SBM.V
50.00%
S&P/TSX Composite index
4.37%

1-Year Return

SBM.V
42.86%
S&P/TSX Composite index
5.70%

3-Year Return

SBM.V
83.78%
S&P/TSX Composite index
14.51%

5-Year Return

SBM.V
70.00%
S&P/TSX Composite index
31.22%

Compare To: SBM.V

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: SBM.V

Valuation Measures

Annual
As of 4/24/2024
  • Market Cap

    15.31M

  • Enterprise Value

    17.54M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    416.87

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    482.60

  • Enterprise Value/EBITDA

    -7.38

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -201.51%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    36.35k

  • Net Income Avi to Common (ttm)

    -2.65M

  • Diluted EPS (ttm)

    -0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    112.98k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -1.02M

Company Insights: SBM.V

People Also Watch